Coulter Partners' top hires for VC & PE portfolio companies Q3 2023
Search HighlightsRecent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
CEO, Medical equipment - France
CEO (US-based), CAR-T therapies - UK
Chief Product Officer, EHR data platform - Spain
Chief Scientific Officer, tRNA-based therapeutics - US
Chief Financial Officer, R&D consulting services - US
Group Chief Financial Officer, Outpatient services (aesthetic medicine) - Switzerland
Chief Business Officer (US-based), AI for drug discovery - Central & Eastern Europe
Head of Business Development, North America, Contract research organisation - Canada
VP Clinical Affairs, Analgesic products - US
VP Operations, Bio-electrical implantable devices - UK
VP Global Program Lead (US-based), Multi-modality biotech - UK
Country Regional Director, Veterinary services - Nordics
Chair, Protein therapeutics - UK
Board Director, Oncology drug discovery - Germany
Newly opened projects include:
CEO, Medical devices - Israel
CEO, Outpatient services - Germany
Country CEO, Healthcare services - Sweden
Chief Strategy Officer, Endoscopic devices - Israel
Chief Product Officer, Medical information services - UK
Chief Medical Officer, Small molecules - Italy
Head of Drug Metabolism & Pharmacokinetics, CNS platform technology - UK
Head of TechOps, Radiopharmaceuticals - China
VP Business Development, Transplant technology - US
VP Sales, Digital pathology solutions - France
Managing Director, Private equity investor - US
Head of Alliance Management, Life sciences incubator - UK
General Manager Infectious Diseases, Biocluster - France
Chair, Digital therapeutics/ devices - US
Board Director, Precision contract manufacturing - US
